Evidence map›Paper›PMID 37103387›Full record

ArticleMarine drugs2023

Slipper Limpet (

Arianna De Mori, Umoru Junior Alasa, Alex Mühlhölzl, Gordon Blunn

Abstract read
In one paragraph

Article in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arianna De MoriSchool of Pharmacy and Biomedical Science, University of Portsmouth, St. Michael's Building, White Swan Road, Portsmouth PO1 2DT, UK.
Umoru Junior AlasaSchool of Pharmacy and Biomedical Science, University of Portsmouth, St. Michael's Building, White Swan Road, Portsmouth PO1 2DT, UK.ORCID 0009-0004-2804-5822
Alex MühlhölzlMikota Ltd., Pembroke Dock, Pembrokeshire, Wales SA72 6AE, UK.
Gordon BlunnSchool of Pharmacy and Biomedical Science, University of Portsmouth, St. Michael's Building, White Swan Road, Portsmouth PO1 2DT, UK.ORCID 0000-0003-2141-7385

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate a cost-effective alternative to man-made calcium phosphate ceramics for treating bone defects. The slipper limpet is an invasive species in European coastal waters, and its shells composed of calcium carbonate could potentially be a cost-effective source of bone graft substitutes. This research analyzed the mantle of the slipper limpet (

Indexed as

Bone SubstitutesOsteogenesisBiocompatible MaterialsBone RegenerationCalcium CarbonateHumansSpectroscopy, Fourier Transform InfraredStem CellsBiocompatible MaterialsBone SubstitutesCalcium Carbonatecalcium carbonateCrepidula fornicatamantlemesenchymal stem cellsosteogenesisslipper limpet shells

Identifiers

PMID37103387
PMCPMC10142914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.